Holen Sie sich die Stockscreener-App
13.45
0.37%
0.05
Handel nachbörslich:
13.45
Schlusskurs vom Vortag:
$13.40
Offen:
$13.4
24-Stunden-Volumen:
1.26M
Relative Volume:
0.79
Marktkapitalisierung:
$1.76B
Einnahmen:
$3.34B
Nettoeinkommen (Verlust:
$97.10M
KGV:
-22.61
EPS:
-0.595
Netto-Cashflow:
$208.00M
1W Leistung:
-1.75%
1M Leistung:
-6.21%
6M Leistung:
-21.16%
1J Leistung:
-41.01%
1-Tages-Spanne:
$13.25
$13.69
1-Wochen-Bereich:
$13.14
$13.88
52-Wochen-Spanne:
$11.41
$24.10
Surgery Partners Inc Stock (SGRY) Company Profile
Firmenname
Surgery Partners Inc
Sektor
Branche
Telefon
615-234-5900
Adresse
340 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
13.45 | 1.75B | 3.34B | 97.10M | 208.00M | -0.595 |
HCA
Hca Healthcare Inc
|
392.42 | 87.42B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
176.38 | 14.97B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
195.57 | 12.74B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.58 | 11.62B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
104.91 | 10.41B | 6.07B | 793.80M | 464.40M | 5.9914 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Fortgesetzt | JP Morgan | Neutral |
| 2025-07-28 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-16 | Eingeleitet | BofA Securities | Buy |
| 2024-10-14 | Eingeleitet | UBS | Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-06-28 | Eingeleitet | Macquarie | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-11-14 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-06-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-05-12 | Eingeleitet | Mizuho | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-11-23 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-06-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-11-30 | Eingeleitet | Barclays | Overweight |
| 2021-11-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-11-01 | Eingeleitet | JP Morgan | Neutral |
| 2021-10-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-06-23 | Fortgesetzt | Stifel | Hold |
| 2020-09-17 | Bestätigt | The Benchmark Company | Buy |
| 2020-04-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-03-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-01-14 | Bestätigt | The Benchmark Company | Buy |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-09-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-06-28 | Hochstufung | Stifel | Sell → Hold |
| 2018-01-30 | Bestätigt | The Benchmark Company | Buy |
| 2017-11-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-08-09 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-08-09 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2017-08-09 | Herabstufung | Stifel | Hold → Sell |
| 2017-04-24 | Bestätigt | Stifel | Hold |
| 2017-03-10 | Herabstufung | Stifel | Buy → Hold |
| 2017-01-31 | Eingeleitet | The Benchmark Company | Buy |
| 2016-06-10 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-03-14 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-10-27 | Eingeleitet | Stifel | Buy |
| 2015-10-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-10-26 | Eingeleitet | Raymond James | Strong Buy |
Alle ansehen
Surgery Partners Inc Aktie (SGRY) Neueste Nachrichten
A Look At Surgery Partners (SGRY) Valuation After A Difficult Year For Shareholders - Yahoo Finance
CORRECTED: Distalmotion Accelerates US Commercial Momentum in Ambulatory Surgery Centers - Yahoo Finance UK
Distalmotion Accelerates US Commercial Momentum in Ambulatory Surgery Centers - Yahoo Finance
Surgery Partners stock (US85701Q1031): Earnings date in focus ahead of August report - AD HOC NEWS
Deals tracker: Medtronic to acquire SPR Therapeutics for $650M - Modern Healthcare
Surgery Partners Inc stock (US85701Q1031): earnings momentum and M&A reshape outlook - AD HOC NEWS
[SCHEDULE 13G/A] Surgery Partners, Inc. Amended Passive Investment Disclosure - Stock Titan
Trading Systems Reacting to (SGRY) Volatility - Stock Traders Daily
5 Revealing Analyst Questions From Surgery Partners’s Q1 Earnings Call - Yahoo Finance
Jefferies Remains Bullish on Surgery Partners (SGRY) Post Q1 - Insider Monkey
Surgery Partners Delivered Solid Q1 Beat Amid Stabilizing Portfolio, RBC Says - Moomoo
BofA Securities Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $17.5 - Moomoo
RBC Capital Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Ambulatory Surgical Centers Market to Reach US$ 162.13 Billion - openPR.com
A Quick Look at Today's Ratings for Surgery Partners(SGRY.US), With a Forecast Between $16.25 to $21 - Moomoo
MSN Money - MSN
A Look At Surgery Partners (SGRY) Valuation After Reaffirmed Guidance And Positive First Quarter Results - Sahm
Is Surgery Partners’ (SGRY) Q1 Beat And Reaffirmed 2026 Outlook Altering The Investment Case? - Yahoo Finance
Stronger Q1 Results And Reaffirmed Outlook Might Change The Case For Investing In Surgery Partners (SGRY) - Sahm
Number of shareholders of Surgery Partners, Inc. – LSX:A14YWP - TradingView
Surgery Partners outlines 2026 revenue of $3.35B-$3.45B and adjusted EBITDA of at least $530M as portfolio optimization targets mid-2026 announcement - MSN
Surgery Partners SGRY Q1 2026 Earnings Transcript - AOL.com
Surgery Partners price target raised to $17 from $15 at Jefferies - TipRanks
Jefferies Maintains Surgery Partners(SGRY.US) With Buy Rating, Raises Target Price to $17 - Moomoo
FMR LLC holds 2.19M SGRY shares (1.7%) — Surgery Partners (NYSE: SGRY) - Stock Titan
Surgery Partners Q1 2026 Earnings Call Transcript - Sahm
Surgery Partners, Inc. (NASDAQ:SGRY) Q1 2026 Earnings Call Transcript - Insider Monkey
Surgery Partners Q1 2026 earnings preview - MSN
KeyBanc Maintains Surgery Partners(SGRY.US) With Hold Rating - Moomoo
Surgery Partners Q1 2026 slides: revenue beats amid regulatory pressures By Investing.com - Investing.com Australia
SGRY Q1 Deep Dive: Stable Margins and Physician Recruitment Offset Volume Headwinds - The Globe and Mail
Surgery Partners Balances Growth Ambitions With Rising Headwinds - TipRanks
Surgery Partners : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
Surgery Partners Q1 Earnings Call Highlights - Yahoo Finance
Surgery Partners (SGRY) Q1 2026 revenue rises as net loss narrows - Stock Titan
Surgery Partners Releases Q1 2026 Financial Results - AlphaStreet
Surgery Partners | 8-K: SURGERY PARTNERS, INC. ANNOUNCES FIRST QUARTER 2026 RESULTS REAFFIRMS FULL YEAR 2026 GUIDANCE - Moomoo
Surgery Partners (SGRY) reports Q1 loss, tops revenue estimates - MSN
Surgery Partners Narrows Slips to a Loss in Q1 2026, Beats Estimates - AlphaStreet
Surgery Partners Q1 2026 slides: revenue beats amid regulatory pressures - Investing.com
Earnings call transcript: Surgery Partners Q1 2026 earnings beat forecasts By Investing.com - Investing.com Australia
Earnings call transcript: Surgery Partners Q1 2026 earnings beat forecasts - Investing.com UK
Surgery Partners Q1 Swings to Adjusted Net Loss, Revenue Rises; Full-Year 2026 Revenue Guidance Reaffirmed - marketscreener.com
Surgery Partners reports Q1 adjusted EPS (3c), consensus (14c) - TipRanks
Finanzdaten der Surgery Partners Inc-Aktie (SGRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Surgery Partners Inc-Aktie (SGRY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Brittenham Marissa | Chief Strategy Officer |
Mar 13 '26 |
Sale |
12.54 |
3,657 |
45,859 |
94,196 |
| Doherty David T | Chief Financial Officer |
Mar 16 '26 |
Sale |
12.50 |
8,867 |
110,838 |
221,679 |
| Evans Jason Eric | Chief Executive Officer |
Mar 16 '26 |
Sale |
12.47 |
20,400 |
254,388 |
920,386 |
| Baldock Jennifer | Chief Admin & Dev Officer |
Mar 12 '26 |
Sale |
13.17 |
5,798 |
76,360 |
326,474 |
2.01%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):